Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IDNA

iShares Genomics Immunology and Healthcare ETF

34.78

Aug 07 • 3:59 PM ET +1.20 (3.58%)

34.78

Aftermarket • 7:34 PM ET 0.00 (0.00%)

Financial Exchange Traded Fund USA NYSE

Category	Global or ExUS Equities - Industry Sector
Sponsor	Blackrock (iShares)
Fund Family
Index	NYSE FactSet Global Genomics and Immuno...
Index Weighting
Active/Passive
Dividend TTM	0.28 (0.81%)
Dividend Ex-Date	Jun 15, 2026
Dividend Gr. 3/5Y	31.32% 20.75%
Expense	0.47%
Inverse/Leveraged
IPO	Jun 13, 2019

Asset Type	Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short	Yes / Yes

Tags	Global
Tags	equity
Tags	healthcare
Tags	genomics
Tags	pharmaceutical
Tags	innovation
Tags	-
Sector/Theme
Region
SMA20	6.17%
SMA50	9.05%
SMA200	19.37%

Return% 1Y	57.18%
Return% 3Y	14.18%
Return% 5Y	-6.78%
Return% 10Y
Return% SI
Flows% 1M	1.72%
Flows% 3M	8.16%
Flows% YTD	16.90%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades

Total Holdings	63
AUM	197.81M
NAV/sh
52W High	34.97 -0.53%
52W Low	21.00 65.61%
Volatility	1.70% 1.87%
ATR (14)	0.70
RSI (14)	68.34
Beta	0.92
Rel Volume	4.38
Avg Volume	46.71K
Volume	204,520

Perf Week	7.58%
Perf Month	0.81%
Perf Quarter	17.70%
Perf Half Y	23.16%
Perf YTD	32.80%
Perf Year	62.98%
Perf 3Y	58.09%
Perf 5Y	-35.27%
Perf 10Y	-
Prev Close	33.58
Price	34.78
Change %	3.58%

Aug-04-26 12:35PM	Moderna Stock Jumps on Trial Launch for Breakthrough Ebola Vaccine (Barrons.com)
Feb-24-26 08:00AM	AI Scare Back in the Market: ETFs That Stayed Steady (Zacks)
Jan-09-26 10:00AM	Here's Why Biotech ETFs Are Rallying Hard (Zacks)
May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
04:33AM	Loading…
04:33AM	Is Healthcare Losing the Status of Safe Haven? ETFs in Focus (Zacks)
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
Apr-20-25 11:28AM	IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (Seeking Alpha)
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.42%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)
Sep-09-22 01:45PM	BlackRock Zeros in on Themed ETFs (ETF.com)
01:30PM	Loading…
Mar-30-22 01:30PM	Vir Jumps 20% On S&P SmallCap 600 News (ETF.com)
Feb-25-22 09:59PM	Best Biotech ETFs for Q2 2022 (Investopedia)
Dec-06-21 10:15AM	BlackRock Releases Megatrends Report (ETF.com)
Oct-21-21 10:15AM	ETF Battles: ARKG Vs IDNA Vs GNOM (ETF.com)
May-18-20 03:42PM	Biotech ETFs to watch as companies push for coronavirus treatments (Yahoo Finance Video) +5.27%
10:51AM	Biotech ETFs trade higher on upbeat coronavirus results (MarketWatch)
Dec-23-19 12:00PM	Will Biotech ETFs Excel in Election Year Post a Surge in 2019? (Zacks)
Dec-18-19 01:41PM	Best & Worst Monthly Performers: December 18 Edition (ETF Database)
Nov-25-19 06:55PM	Genomics ETFs Surge on CRISPR's Gene Editing Progress (Zacks)
Nov-21-19 12:56PM	Best & Worst Monthly Performers: November 21 Edition (ETF Database)
Nov-04-19 01:00PM	Value Biotech ETFs & Stocks to Buy Now (Zacks)
Oct-23-19 10:10AM	Biotech ETFs Surge on a Flurry of Positive News (Zacks)
Sep-06-19 03:07PM	ETFs Poised to Benefit from Gene Editing Revolution (Zacks)
Sep-04-19 03:18PM	ETFs to Gain From the Booming Genomics Market (Zacks)

iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma IndexTM. The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.

open in yahoo | open in marketwatch | open in google

IDNA

iShares Genomics Immunology and Healthcare ETF

Upgrade your Finviz experience